In conclusion, we found that CD47 is expressed on lung cancer cells and lung CSCs, and CD47 and CD133 levels as prognostic factors can be useful in risk-adapted therapy decision-making of lung cancer patients. The gene discussed is CD47; the disease is lung cancer.